CoChat

Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation

Bäck, Magnus, Hansson, Göran K. · 2019 · The FASEB Journal
Cited by 104

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Although a high marine food intake is considered cardioprotective, randomized trials of ω‐3 fatty acids initially generated conflicting results in terms of the role of ω‐3 supplementation in cardiovascular prevention. This work demonstrates the results of the 3 most recent clinical trials with ω‐3 fatty acids are put into the context of possible mechanisms mediating their beneficial cardiovascular effects. In particular, the randomized Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE‐IT) showed that icosapent ethyl, which is the ethyl ester form of the ω‐3 fatty acid eicosapentaenoic acid (EPA), induced a significant reduction of cardiovascular events. Importantly, EPA serves as a substrate for the formation of the specialized proresolving mediator resolvin E1 (RvE1), which stimulates the resolution of inflammation. RvE1 reduces atherosclerosis and intimai hyperplasia by means of its specific receptor ERV1/ChemR23. The decreased levels of proinflammatory and proatherosclerotic leukotrienes by ω‐3 fatty acids may further contribute to a beneficial inflammatory balance. Consequently, the Rv/leukotriene ratio is emerging as a marker of nonresolving vascular inflammation. Recent experimental studies have shown that anti‐inflammatory and proresolving effects of lipid mediators derived from ω‐3 fatty acids inhibit atherosclerosis independently of cholesterol and triglyceride levels. The results of the 3 most recent clinical trials of ω‐3 fatty acid supplementation indicate an importance of the type and dose of ω‐3 supplementation and highlight the need for risk stratification in the patient selection for ω‐3 supplementation for either primary or secondary prevention of cardiovascular disease.—Bäck, M., Hansson, G. K. Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation. FASEB J. 33, 1536–1539 (2019). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201802445r

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 104

Metadata

Authors
Bäck, M., & Hansson, G. K.
Venue
The FASEB Journal
Publisher
Wiley
Published
2019-01-17
Volume
33
Issue
2
Pages
1536-1539
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2911252450
Cited by
104
References
9
FWCI
10.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation. https://app.cochat.ai/papers/10.1096/fj.201802445r
The paper
Bäck, M., & Hansson, G. K. (2019). Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation. The FASEB Journal. https://doi.org/10.1096/fj.201802445r

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.